PROVIDER PROFILE · NPI 1306611280
Kelly Borgerding
PRESCRIBING · PART D · 2024
Total Rx claims
21
Beneficiaries
—
Total drug cost
$26K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Tirzepatide21 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE